LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast

In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts

July 16, 2024

At Prime Therapeutics/Magellan Rx Management (Prime/Magellan Rx), we strive to provide the same care we would want for our loved ones. This purpose extends beyond employees to encompass our members, clients and communities.

In this special Power of People edition of the Pharmacy Friends podcast, Laura Spitzack, director of communications at Prime/Magellan Rx, discusses how our employees’ help goes beyond our work in health care. On any given day, Prime/Magellan Rx’s people can be found serving others in the communities where we live and work.

Featured in this episode is Kerry Florian, vice president, total rewards, who discusses how Prime/Magellan Rx’s community giving program, PrimeCares, brings employees together to donate, volunteer and participate in community events. She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation.

Also featured is guest Becky DeRosia, senior development officer, Hennepin Healthcare Foundation, who talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are in instrumental in their work.

“Introducing these new populations to careers in healthcare, not just being a doctor, is important,” DeRosia said. “There’s so many phenomenal careers in nursing, medical aid, administration, etc. It’s really about opening their eyes.”

Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming and, most importantly, what it means to you. Listen to the full episode  “Beyond the business – Stories of corporate kindness,” on primetherapeutics.com/pharmacy-friends.

Related news

Perspectives

July 22, 2024

Oncology Insights: 2024 ASCO Annual Meeting key findings

Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions

Perspectives

July 12, 2024

August 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market

Perspectives

July 12, 2024

High-Cost Therapy Profile: July 2024

Detailed information about Afamitresgene autoleucel Intravenous (IV)